Wikidata

(Q40579896)

English

Combination with liposome-entrapped, ends-modified raf antisense oligonucleotide (LErafAON) improves the anti-tumor efficacies of cisplatin, epirubicin, mitoxantrone, docetaxel and gemcitabine

scientific article published on March 2004

In more languages

Statements

title
Combination with liposome-entrapped, ends-modified raf antisense oligonucleotide (LErafAON) improves the anti-tumor efficacies of cisplatin, epirubicin, mitoxantrone, docetaxel and gemcitabine (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
author name string
Jin Pei
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
Chuanbo Zhang
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
Prafulla C Gokhale
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
Aquilur Rahman
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
Anatoly Dritschilo
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
Imran Ahmad
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
Usha N Kasid
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
publication date
1 March 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017
page(s)
243-253
1 reference
stated in
Europe PubMed Central
PubMed ID
15014358
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40579896&oldid=1903228945"